ID: ALA4103831

Max Phase: Preclinical

Molecular Formula: C14H10F3N3

Molecular Weight: 277.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1cc(-c2c[nH]c3cc(C(F)(F)F)ccc23)ccn1

Standard InChI:  InChI=1S/C14H10F3N3/c15-14(16,17)9-1-2-10-11(7-20-12(10)6-9)8-3-4-19-13(18)5-8/h1-7,20H,(H2,18,19)

Standard InChI Key:  NPPYMINKJWTKBH-UHFFFAOYSA-N

Associated Targets(Human)

Glycogen synthase kinase-3 beta 11785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dual-specificity tyrosine-phosphorylation regulated kinase 1A 6484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear factor of activated T-cells cytoplasmic 1 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 277.25Molecular Weight (Monoisotopic): 277.0827AlogP: 3.83#Rotatable Bonds: 1
Polar Surface Area: 54.70Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.42CX LogP: 3.14CX LogD: 3.10
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.71Np Likeness Score: -0.19

References

1. Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM..  (2017)  Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.,  27  (11): [PMID:28408219] [10.1016/j.bmcl.2017.03.037]

Source